XLO
USDXilio Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$0.850
High
$0.858
Low
$0.793
Volume
1.10M
Company Fundamentals
Market Cap
41.6M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.67M
Exchange
NCM
Currency
USD
52-Week Range
Related News
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living
Xilio Therapeutics to Present Phase 2 Data for Vilastobart Highlighting Response Rate in Patients with MSS mCRC and High Plasma Tumor Mutational Burden as a Late-Breaking Presentation at SITC 40th Annual Meeting
WALTHAM, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living
Related Stocks
UZE
United States Cellular Corporation 5.500% Senior Notes due 2070
OCX
Oncocyte Corporation
OXLCL
Oxford Lane Capital Corp. 6.75% Notes due 2031
GHI
Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
CVCO
Cavco Industries Inc. When Issued
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.